Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
INR 15.2
(-4.94%)
INR 15.2
(-4.94%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 216.59 Million INR | 218.16% |
| 2022 | 64.96 Million INR | 108.2% |
| 2021 | 29.35 Million INR | 64.58% |
| 2020 | 17.53 Million INR | 23.66% |
| 2019 | 15.4 Million INR | -12.74% |
| 2018 | 16.49 Million INR | 2.11% |
| 2017 | 16.15 Million INR | 10.29% |
| 2016 | 14.64 Million INR | 24.07% |
| 2015 | 11.8 Million INR | 578.24% |
| 2014 | -2.46 Million INR | -164.46% |
| 2013 | -933.38 Thousand INR | -116.23% |
| 2012 | 5.34 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 8.58 Million INR | -88.74% |
| 2023 Q3 | 95.44 Million INR | 79.06% |
| 2023 FY | - INR | 218.16% |
| 2023 Q1 | 9.7 Million INR | -78.51% |
| 2023 Q2 | 53.3 Million INR | 449.13% |
| 2023 Q4 | 44.33 Million INR | -53.54% |
| 2022 Q1 | 9.62 Million INR | -77.35% |
| 2022 FY | - INR | 108.2% |
| 2022 Q2 | 5.01 Million INR | -47.9% |
| 2022 Q4 | 45.16 Million INR | 714.59% |
| 2022 Q3 | 5.54 Million INR | 10.63% |
| 2021 Q2 | -19.41 Million INR | -1022.53% |
| 2021 Q4 | 42.47 Million INR | 1050.69% |
| 2021 Q3 | 3.69 Million INR | 119.02% |
| 2021 Q1 | 2.1 Million INR | -25.79% |
| 2021 FY | - INR | 64.58% |
| 2020 Q4 | 2.83 Million INR | -56.91% |
| 2020 Q1 | 3.81 Million INR | 925.02% |
| 2020 FY | - INR | 23.66% |
| 2020 Q2 | 4.57 Million INR | 20.03% |
| 2020 Q3 | 6.58 Million INR | 43.89% |
| 2019 Q3 | 9.52 Million INR | 150.83% |
| 2019 FY | - INR | -12.74% |
| 2019 Q1 | 1.53 Million INR | -80.05% |
| 2019 Q4 | -461.8 Thousand INR | -104.85% |
| 2019 Q2 | 3.79 Million INR | 147.52% |
| 2018 FY | - INR | 2.11% |
| 2018 Q4 | 7.68 Million INR | 239.46% |
| 2018 Q3 | 2.26 Million INR | -1.26% |
| 2018 Q2 | 2.29 Million INR | -41.12% |
| 2018 Q1 | 3.89 Million INR | 286.59% |
| 2017 Q1 | 2.29 Million INR | -66.91% |
| 2017 Q2 | 845 Thousand INR | -63.13% |
| 2017 Q3 | 15.58 Million INR | 1744.02% |
| 2017 Q4 | -2.08 Million INR | -113.4% |
| 2017 FY | - INR | 10.29% |
| 2016 Q4 | 6.92 Million INR | 186.2% |
| 2016 FY | - INR | 24.07% |
| 2016 Q3 | 2.42 Million INR | 202.46% |
| 2016 Q2 | -2.36 Million INR | -176.22% |
| 2016 Q1 | 3.09 Million INR | -74.16% |
| 2015 FY | - INR | 578.24% |
| 2015 Q4 | 11.99 Million INR | 1253.39% |
| 2015 Q3 | 886 Thousand INR | -63.22% |
| 2015 Q2 | 2.4 Million INR | -18.45% |
| 2015 Q1 | 2.95 Million INR | 116.82% |
| 2014 Q1 | 2.01 Million INR | -79.96% |
| 2014 Q3 | 669 Thousand INR | -74.4% |
| 2014 FY | - INR | -164.46% |
| 2014 Q4 | -17.55 Million INR | -2724.57% |
| 2014 Q2 | 2.61 Million INR | 29.81% |
| 2013 Q3 | -1.33 Million INR | 58.98% |
| 2013 Q2 | -3.25 Million INR | 13.05% |
| 2013 Q1 | -3.74 Million INR | -110.6% |
| 2013 FY | - INR | -116.23% |
| 2013 Q4 | 10.04 Million INR | 852.29% |
| 2012 Q3 | 1.55 Million INR | -28.75% |
| 2012 FY | - INR | 0.0% |
| 2012 Q2 | 2.18 Million INR | 143.4% |
| 2012 Q1 | -5.02 Million INR | 81.94% |
| 2012 Q4 | 35.29 Million INR | 2171.45% |
| 2011 Q2 | 5.11 Million INR | 0.0% |
| 2011 Q3 | 300 Thousand INR | -94.14% |
| 2011 Q4 | -27.82 Million INR | -9375.05% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | -138.903% |
| Add-Shop E-Retail Limited | 82.61 Million INR | -162.173% |
| Bacil Pharma Limited | -569.32 Thousand INR | 38144.334% |
| Beryl Drugs Limited | 26.63 Million INR | -713.071% |
| Cian Healthcare Limited | 122.56 Million INR | -76.715% |
| Colinz Laboratories Limited | 5.42 Million INR | -3890.31% |
| Concord Drugs Limited | 40.52 Million INR | -434.536% |
| Deccan Health Care Limited | 37.5 Million INR | -477.492% |
| Gennex Laboratories Limited | 219.35 Million INR | 1.26% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -1264.2% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -1721.955% |
| Kerala Ayurveda Limited | 70.78 Million INR | -205.98% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 64.519% |
| Mercury Laboratories Limited | 101.18 Million INR | -114.051% |
| Panchsheel Organics Limited | 189.36 Million INR | -14.378% |
| Parmax Pharma Limited | 22.93 Million INR | -844.279% |
| Parnax Lab Limited | 243.59 Million INR | 11.086% |
| Patidar Buildcon Limited | -5.52 Million INR | 4019.544% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 275.69% |
| Phaarmasia Limited | -1.58 Million INR | 13791.15% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -696.506% |
| Sastasundar Ventures Limited | -203.51 Million INR | 206.428% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | -143.337% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -383.426% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 14.785% |
| Sunil Healthcare Limited | 93.07 Million INR | -132.699% |
| Syschem (India) Limited | 70.4 Million INR | -207.658% |
| Trident Lifeline Limited | 102.69 Million INR | -110.914% |
| Transchem Limited | 56.61 Million INR | -282.601% |
| Tyche Industries Limited | 128.2 Million INR | -68.941% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 44.021% |
| Vasundhara Rasayans Limited | 84.22 Million INR | -157.158% |
| Zenith Healthcare Limited | 4.98 Million INR | -4242.302% |
| Zenotech Laboratories Limited | 172.64 Million INR | -25.456% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -33808.829% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -1769.769% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -1211.26% |
| MedPlus Health Services Limited | 3.94 Billion INR | 94.504% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | -147.303% |
| Smruthi Organics Limited | 120.31 Million INR | -80.027% |
| Trimurthi Limited | -2.47 Million INR | 8838.879% |
| Zenlabs Ethica Limited | 27.09 Million INR | -699.358% |
| Makers Laboratories Limited | 25.81 Million INR | -739.121% |
| Lactose (India) Limited | 201.22 Million INR | -7.639% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 243.389% |
| Roopa Industries Limited | 55.7 Million INR | -288.851% |
| PANJON LTD. | 4.08 Million INR | -5196.992% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 1236.857% |
| Anuh Pharma Limited | 878.5 Million INR | 75.345% |
| Crestchem Limited | 30.33 Million INR | -614.023% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 2102.163% |
| PRAVEG LIMITED | 321.43 Million INR | 32.617% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 44.317% |
| Norris Medicines Limited | -1.78 Million INR | 12239.933% |
| Denis Chem Lab Limited | 224.84 Million INR | 3.671% |
| Veerhealth Care Limited | 15.99 Million INR | -1254.136% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 42.679% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 325.218% |
| Godavari Drugs Limited | 134.62 Million INR | -60.887% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 53448.276% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | -26.981% |
| Vivanza Biosciences Limited | 11.2 Million INR | -1833.185% |
| Medi-Caps Limited | 4.77 Million INR | -4439.803% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 8063.015% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 51.737% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 73.936% |
| Bharat Parenterals Limited | 265.74 Million INR | 18.495% |
| BDH Industries Limited | 124.27 Million INR | -74.289% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 768.934% |
| Coral Laboratories Limited | 227.07 Million INR | 4.616% |
| Evoq Remedies Limited | 6.18 Million INR | -3400.24% |
| Trinity League India Limited | -26.25 Million INR | 925.026% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 2626.467% |
| Natural Capsules Limited | 219.9 Million INR | 1.503% |
| Auro Laboratories Limited | 121.73 Million INR | -77.921% |